Φορτώνει......
Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapy
Engineered protein therapeutics offer advantages, including strong target affinity, selectivity, and low toxicity, but like natural proteins can be susceptible to proteolytic degradation, thereby limiting their effectiveness. A compelling therapeutic target is mesotrypsin, a protease upregulated wit...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Biochem J |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4898653/ https://ncbi.nlm.nih.gov/pubmed/26957636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BJ20151410 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|